Literature DB >> 3923270

An improved fluorimetric assay for brain monoamine oxidase.

A Morinan, H M Garratt.   

Abstract

A fluorimetric assay for monamine oxidase that uses kynuramine as the substrate is described. This method is more economic, rapid, reproducible, and sensitive than other similar procedures. Its validity has been confirmed by the study of the subcellular distribution, the effects of inhibitors, and the kinetics of enzyme activity. Previous reports of substrate inhibition by kynuramine may have to be reassessed in the light of evidence presented here.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3923270     DOI： 10.1016/0160-5402(85)90021-x

Source DB:  PubMed          Journal:  J Pharmacol Methods        ISSN： 0160-5402


  13 in total

1.  Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency.

Authors:  T Sengupta; J Vinayagam; N Nagashayana; B Gowda; P Jaisankar; K P Mohanakumar
Journal:  Neurochem Res       Date:  2010-10-23       Impact factor: 3.996

2.  Characterization of Euphorbia characias latex amine oxidase.

Authors:  A Padiglia; R Medda; A Lorrai; B Murgia; J Z Pedersen; A Finazzi Agró; G Floris
Journal:  Plant Physiol       Date:  1998-08       Impact factor: 8.340

3.  Neuroprotective effect of curcuminoids against inflammation-mediated dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.

Authors:  Rudra P Ojha; Manisha Rastogi; B Parimala Devi; Aruna Agrawal; G P Dubey
Journal:  J Neuroimmune Pharmacol       Date:  2012-04-21       Impact factor: 4.147

4.  Increased expression of prion protein is associated with changes in dopamine metabolism and MAO activity in PC12 cells.

Authors:  H G Lee; S J Park; E K Choi; R I Carp; Y S Kim
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

Review 5.  Clinical pharmacokinetics and pharmacodynamics of selegiline. An update.

Authors:  I Mahmood
Journal:  Clin Pharmacokinet       Date:  1997-08       Impact factor: 6.447

6.  Comprehensive in Vitro Characterization of the LSD1 Small Molecule Inhibitor Class in Oncology.

Authors:  Natalia Sacilotto; Paola Dessanti; Michele M P Lufino; Alberto Ortega; Alejandra Rodríguez-Gimeno; Jordi Salas; Tamara Maes; Carlos Buesa; Cristina Mascaró; Robert Soliva
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-12

Review 7.  Selective MAO-B inhibitors: a lesson from natural products.

Authors:  Simone Carradori; Melissa D'Ascenzio; Paola Chimenti; Daniela Secci; Adriana Bolasco
Journal:  Mol Divers       Date:  2013-11-12       Impact factor: 2.943

8.  Dopamine agonist 3-PPP fails to protect against MPTP-induced toxicity.

Authors:  Dhanasekaran Muralikrishnan; Manuchair Ebadi; Holly M Brown-Borg
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

9.  EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity.

Authors:  Patricia Rojas; Carolina Rojas; Manuchair Ebadi; Sergio Montes; Antonio Monroy-Noyola; Norma Serrano-García
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

10.  Dereplication of Components Coupled with HPLC-qTOF-MS in the Active Fraction of Humulus japonicus and It's Protective Effects against Parkinson's Disease Mouse Model.

Authors:  Hee Ju Lee; Basanta Dhodary; Ju Yong Lee; Jin-Pyo An; Young-Kyoung Ryu; Kyoung-Shim Kim; Chul-Ho Lee; Won Keun Oh
Journal:  Molecules       Date:  2019-04-11       Impact factor: 4.927
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.